Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 64%
Hold 0%
Sell 0%
Strong Sell 9%

Bulls say

HealthEquity is well-positioned for growth and margin expansion, driven by continued market share penetration, increasing penetration of its Enhanced Rates product, and leveraging technology to drive down service costs. The regulatory landscape is also favorable for potential TAM expansion. With attractive valuation and solid execution, the company is a strong buy opportunity for investors.

Bears say

HealthEquity is facing potential challenges as the market for health savings accounts (HSAs) is highly competitive and oversaturated, and their growth may slow significantly due to a weakening labor market and lower adoption rates for enhanced yield offerings. While the company has shown strong account growth and a diversified product portfolio, our downside scenario assumes slower growth and margin contraction, leading to a $79 price target. However, there is potential for an upside scenario with a $119 price target if the company achieves better-than-expected penetration of enhanced rates, accelerated growth in other consumer-directed benefits, and continued benefits from technology investments.

HealthEquity (HQY) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 64% recommend Buy, 0% suggest Holding, 0% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 11 analysts, HealthEquity (HQY) has a Buy consensus rating as of Aug 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $114.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $114.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.